E.E.S

Product NDC: 80005-153
Requested package NDC: 80005-153-34
11-digit product format: 800050153
Labeler code: 80005
Product ID: 80005-153_ad0b7a24-6fae-4dfd-a308-4fd9c543d7e1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Erythromycin Ethylsuccinate
Dosage form: GRANULE, FOR SUSPENSION
Route: ORAL
Labeler: Carnegie Pharmaceuticals LLC
Application: NDA050207
Marketing category: NDA
Marketing start: 2025-01-15
Substance: ERYTHROMYCIN ETHYLSUCCINATE
Active strength: 200 mg/5mL
Pharmacologic classes: Decreased Sebaceous Gland Activity [PE], Macrolide Antimicrobial [EPC], Macrolide [EPC], Macrolides [CS]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded package	package	80005-153	80005-153-34	I	Inactivated by FDA		2026-08-03

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N050207-001	E.E.S.	ERYTHROMYCIN ETHYLSUCCINATE	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982
N050207-002	ERYPED	ERYTHROMYCIN ETHYLSUCCINATE	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982
N050207-003	ERYPED	ERYTHROMYCIN ETHYLSUCCINATE	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N050207-001	AB
N050207-002	AB
N050207-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-002	ERYPED	EQ 400MG BASE/5ML	GRANULE / ORAL	AB	RLD, RS, Approved before 1982		`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-003	ERYPED	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD	1987-03-30	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050207-001	E.E.S.	EQ 200MG BASE/5ML	GRANULE / ORAL	AB	RLD, Approved before 1982		`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	N050207-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N050207-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N050207-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N050207-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N050207-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N050207-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N050207-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N050207-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N050207-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N050207-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N050207-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N050207-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N050207-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N050207-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N050207-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	N050207-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	N050207-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d329c2e1-5ae8-4e64-aea0-77ecea3fa1ab	Product name	3	20250717
3b331500-3b74-bd2b-fede-d46839f2f4d5	Product name	6	20240313
fdae2630-eae0-4769-abfd-8f33d5b771b4	Product name	3	20240202
8c898317-b543-1e4e-254f-84cec2f3f57e	Product name	2	20191002
64ae94c0-3212-d73a-92da-9e6dd85c6ebe	Product name	2	20180118
edcfa1cf-915f-1a4c-d0aa-508cc66e70d9	Product name	2	20170816
ad75fcfd-a339-42a1-9c60-43ba2c654cfa	Product name	1	20170810
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
57850177-5927-151f-e1fa-7e2ca47f81e5	Product name	1	20140508
8ee71591-1d8f-e24e-242b-bfef131e3168	Product name	1	20140508
bff5cf99-0f45-fa15-2a76-b160c3c4cc3c	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
80005-153-34	E.E.S	200 mL in 1 BOTTLE	GRANULE, FOR SUSPENSION	200		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
80005-153-34	ML - Milliliter	80005-153	7e51a994-90db-4989-ac32-460a7e6ee2e2	1	2025-03-04

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
80005-153	E.E.S 400 (ERYTHROMYCIN ETHYLSUCCINATE) TABLET E.E.S (ERYTHROMYCIN ETHYLSUCCINATE) GRANULE, FOR SUSPENSION [CARNEGIE PHARMACEUTICALS LLC]	2	Current NDC, 1 package rows	20250226_91479d92-3bf3-4eb3-81bd-8ce4956d4347.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
E.E.S 400	ERYTHROMYCIN ETHYLSUCCINATE	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	b455bbdb-a3f1-470f-aa5f-ed83ac2e228d	2023-12-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207
Ery-Ped	ERYTHROMYCIN ETHYLSUCCINATE	Azurity Pharmaceuticals, Inc. (formerly Arbor Pharmaceuticals)	04775721-ab87-4b66-808c-d67a21032385	2023-12-16	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207
ERYTHROMYCIN ETHYLSUCCINATE	ERYTHROMYCIN ETHYLSUCCINATE	Wilshire Pharmaceuticals	86d6353c-2b58-4219-b31d-fb5b97789094	2020-09-24	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207
Erythromycin Ethylsuccinate	ERYTHROMYCIN ETHYLSUCCINATE	Wilshire Pharmaceuticals Inc.	f4a3fffd-ce02-450f-bbcc-d425374e3e32	2019-01-29	Warnings, Adverse reactions	Exact identifier application applno (NDA): 050207 application number: NDA050207

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
1014KSJ86F	ERYTHROMYCIN ETHYLSUCCINATE	1264-62-6	ERYTHROMYCIN ETHYLSUCCINATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
863603	E.E.S. 200 MG in 5 mL Oral Suspension	PSN	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863606	E.E.S. 400 MG Oral Tablet	PSN	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686400	erythromycin ethylsuccinate 200 MG in 5 mL Oral Suspension	PSN	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686405	erythromycin ethylsuccinate 400 MG Oral Tablet	PSN	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863603	erythromycin ethylsuccinate 40 MG/ML Oral Suspension [E.E.S.]	SBD	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863606	erythromycin ethylsuccinate 400 MG Oral Tablet [E.E.S.]	SBD	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686400	erythromycin ethylsuccinate 40 MG/ML Oral Suspension	SCD	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686405	erythromycin ethylsuccinate 400 MG Oral Tablet	SCD	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863603	E.E.S. 200 MG per 5 ML Oral Suspension	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863603	E.E.S. 200 Oral Suspension	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863603	E.E.S. 40 MG/ML Oral Suspension	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863606	E.E.S. 400 MG Oral Tablet	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686400	EES 40 MG/ML Oral Suspension	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863603	EES 40 MG/ML Oral Suspension [E.E.S.]	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686405	EES 400 MG Oral Tablet	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
863606	EES 400 MG Oral Tablet [E.E.S.]	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2
686400	erythromycin ethylsuccinate 200 MG per 5 ML Oral Suspension	SY	91479d92-3bf3-4eb3-81bd-8ce4956d4347	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Sample	Exclude flag	Status
80005-153-34	80005015334	200 mL in 1 BOTTLE (80005-153-34)	200 ml	2025-01-15	No	No	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
E.E.S. ® (ERYTHROMYCIN ETHYLSUCCINATE)	Carnegie Pharmaceuticals LLC \| Azurity Pharmaceuticals Inc (Formerly Arbor Pharmaceuticals)	2025-02-21	HUMAN PRESCRIPTION DRUG LABEL	2